LSM1
Basic information
Region (hg38): 8:38163335-38176730
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LSM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 9 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 0 | 0 |
Variants in LSM1
This is a list of pathogenic ClinVar variants found in the LSM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-38163695-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
8-38169798-T-G | 19 conditions • Complex neurodevelopmental disorder | Uncertain significance (May 28, 2020) | ||
8-38169822-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
8-38169840-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
8-38169857-A-C | not specified | Uncertain significance (Oct 05, 2023) | ||
8-38169887-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
8-38169915-T-A | Global developmental delay | Likely pathogenic (-) | ||
8-38171994-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
8-38172008-A-C | not specified | Uncertain significance (Sep 17, 2021) | ||
8-38172012-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
8-38172015-A-G | not specified | Uncertain significance (Dec 07, 2023) | ||
8-38176278-C-T | not specified | Uncertain significance (Jun 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LSM1 | protein_coding | protein_coding | ENST00000311351 | 4 | 13410 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0110 | 0.850 | 125738 | 0 | 7 | 125745 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.00 | 48 | 71.9 | 0.668 | 0.00000359 | 862 |
Missense in Polyphen | 14 | 22.173 | 0.63141 | 262 | ||
Synonymous | 0.554 | 22 | 25.6 | 0.861 | 0.00000120 | 262 |
Loss of Function | 1.20 | 4 | 7.57 | 0.528 | 4.53e-7 | 79 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000665 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the degradation of histone mRNAs, the only eukaryotic mRNAs that are not polyadenylated (PubMed:18172165). Probably also part of an LSm subunits- containing complex involved in the general process of mRNA degradation (By similarity). {ECO:0000250|UniProtKB:P47017, ECO:0000269|PubMed:18172165}.;
- Pathway
- RNA degradation - Homo sapiens (human);Metabolism of RNA;mRNA decay by 5, to 3, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.39
Haploinsufficiency Scores
- pHI
- 0.571
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Low | Medium |
Mouse Genome Informatics
- Gene name
- Lsm1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- deadenylation-dependent decapping of nuclear-transcribed mRNA;RNA splicing, via transesterification reactions;mRNA processing;RNA splicing;RNA metabolic process;stem cell population maintenance;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;negative regulation of neuron differentiation;histone mRNA catabolic process
- Cellular component
- P-body;nucleus;cytoplasm;cytosol;axon;dendrite;neuronal cell body;messenger ribonucleoprotein complex;Lsm1-7-Pat1 complex
- Molecular function
- RNA cap binding;RNA binding;mRNA binding;protein binding;pre-mRNA binding